These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 10327329)

  • 1. [Reflections on GPIIb/IIIA inhibitors ... and all around ...].
    Neri Serneri GG
    G Ital Cardiol; 1999 Apr; 29(4):467-71. PubMed ID: 10327329
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiplatelet therapies: platelet GPIIb/IIIa antagonists and beyond.
    Konstantopoulos K; Mousa SA
    Curr Opin Investig Drugs; 2001 Aug; 2(8):1086-92. PubMed ID: 11892918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of glycoprotein IIb/IIIa receptor inhibitors in unstable angina.
    Ageno W; Turpie AG
    G Ital Cardiol; 1999 Nov; 29(11):1357-65. PubMed ID: 10609142
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral glycoprotein IIb/IIIa receptor inhibitors in patients with cardiovascular disease: why were the results so unfavourable.
    Leebeek FW; Boersma E; Cannon CP; van de Werf FJ; Simoons ML
    Eur Heart J; 2002 Mar; 23(6):444-57. PubMed ID: 11863347
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet GPIIb/IIIa antagonist, XV459, in heparin-induced thrombocytopenia.
    Mousa SA; Ahmad S
    Am J Hematol; 2007 Apr; 82(4):276-82. PubMed ID: 17039513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year experience with the platelet glycoprotein IIb/IIIa antagonist tirofiban and heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II.
    Koster A; Meyer O; Fischer T; Kukucka M; Krabatsch T; Bauer M; Kuppe H; Hetzer R
    J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1254-5. PubMed ID: 11726910
    [No Abstract]   [Full Text] [Related]  

  • 7. The evolving role of glycoprotein IIb/IIIa inhibitor therapy in contemporary care of acute coronary syndrome patients.
    Tricoci P; Peterson ED
    J Interv Cardiol; 2006 Oct; 19(5):449-55. PubMed ID: 17020570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycoprotein IIb/IIIa antagonists in acute coronary syndromes.
    Maree A; Fitzgerald D
    Haematologica; 2001 Nov; 86(11 Suppl 2):45-8. PubMed ID: 11926777
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet glycoprotein IIb/IIIa inhibitors.
    Rosove MH
    Best Pract Res Clin Haematol; 2004 Mar; 17(1):65-76. PubMed ID: 15171958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IIb/IIIa Receptor Blockers. Preface.
    van den Brand M; O'Neill W
    Semin Interv Cardiol; 1999 Jun; 4(2):59-60. PubMed ID: 10473873
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blockers of platelet glycoprotein IIb/IIIa-receptors in the treatment of patients with acute coronary syndrome and during transcutaneous coronary interventions].
    Fettser DV; Preobrazhenskiĭ DV; Batyraliev TA; Sidorenko BA; Aĭtach V
    Ter Arkh; 2009; 81(1):84-7. PubMed ID: 19253720
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of platelet glycoprotein IIb/IIIa receptor antagonists during the acute phase of myocardial infarction.
    van den Brand M; Ronner EF
    Semin Interv Cardiol; 1999 Jun; 4(2):85-8. PubMed ID: 10473877
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet glycoprotein IIb/IIIa antagonists: perioperative implications.
    Sreeram GM; Sharma AD; Slaughter TF
    J Cardiothorac Vasc Anesth; 2001 Apr; 15(2):237-40. PubMed ID: 11312488
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical studies on glycoprotein IIb/IIIa receptor antagonist].
    Rasmussen LH; Husted SE; Clemmensen PM; Gøtzsche CO; Helqvist S; Kristensen SD; Pedersen KE; Rasmussen K; Rasmussen S
    Ugeskr Laeger; 2000 Oct; 162(44):5944-7. PubMed ID: 11094564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cold start for oral glycoprotein IIb/IIIa antagonists.
    Curtin R; Fitzgerald DJ
    Eur Heart J; 2000 Dec; 21(24):1992-4. PubMed ID: 11102247
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute coronary syndrome: are intervention and IIb/IIIa platelet inhibitors epiphenomena?
    Jackson G
    Int J Clin Pract; 2001; 55(6):351-2. PubMed ID: 11501219
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety of the use of IIb/IIIa receptor blockers with or without the use of other anticoagulants.
    Ferguson JJ; Lau TK
    Semin Interv Cardiol; 1999 Jun; 4(2):97-102. PubMed ID: 10473879
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Quinn MJ; Moliterno DJ
    Minerva Cardioangiol; 2002 Oct; 50(5):547-53. PubMed ID: 12384636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controversies surrounding platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention and acute coronary syndromes.
    Harrington RA
    Semin Thromb Hemost; 2004 Dec; 30(6):639-47. PubMed ID: 15630670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of GPIIb/IIIa inhibitors in cardiovascular medicine.
    Ahrens I; Peter K; Bode C
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):233-42. PubMed ID: 15030283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.